TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 234 filers reported holding TG THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $572,510 | -65.1% | 68,482 | +3.7% | 0.00% | -60.0% |
| Q2 2023 | $1,640,607 | +69.7% | 66,047 | +2.7% | 0.01% | +66.7% |
| Q1 2023 | $966,892 | +29.7% | 64,288 | +2.0% | 0.01% | +20.0% |
| Q4 2022 | $745,396 | +99.3% | 63,009 | -0.4% | 0.01% | +66.7% |
| Q3 2022 | $374,000 | +41.1% | 63,238 | +1.4% | 0.00% | +50.0% |
| Q2 2022 | $265,000 | -56.7% | 62,345 | -3.1% | 0.00% | -33.3% |
| Q1 2022 | $612,000 | -53.2% | 64,307 | -6.6% | 0.00% | -57.1% |
| Q4 2021 | $1,308,000 | -44.0% | 68,834 | -1.9% | 0.01% | -41.7% |
| Q3 2021 | $2,335,000 | -16.2% | 70,161 | -2.3% | 0.01% | +33.3% |
| Q2 2021 | $2,786,000 | -22.0% | 71,828 | -3.0% | 0.01% | -30.8% |
| Q1 2021 | $3,570,000 | -2.8% | 74,075 | +4.9% | 0.01% | -7.1% |
| Q4 2020 | $3,673,000 | +106.7% | 70,606 | +6.3% | 0.01% | +55.6% |
| Q3 2020 | $1,777,000 | +54.4% | 66,400 | +12.4% | 0.01% | +50.0% |
| Q2 2020 | $1,151,000 | +129.3% | 59,071 | +15.8% | 0.01% | +100.0% |
| Q1 2020 | $502,000 | -16.2% | 51,014 | -5.5% | 0.00% | +50.0% |
| Q4 2019 | $599,000 | +105.8% | 53,961 | +4.2% | 0.00% | +100.0% |
| Q3 2019 | $291,000 | -32.6% | 51,790 | +3.6% | 0.00% | -50.0% |
| Q2 2019 | $432,000 | +34.2% | 49,991 | +24.8% | 0.00% | +100.0% |
| Q1 2019 | $322,000 | +89.4% | 40,051 | -3.1% | 0.00% | 0.0% |
| Q4 2018 | $170,000 | -27.0% | 41,350 | -0.8% | 0.00% | 0.0% |
| Q3 2018 | $233,000 | -54.0% | 41,667 | +8.1% | 0.00% | -50.0% |
| Q2 2018 | $507,000 | +8.8% | 38,541 | +17.4% | 0.00% | 0.0% |
| Q1 2018 | $466,000 | +64.1% | 32,823 | -5.1% | 0.00% | +100.0% |
| Q4 2017 | $284,000 | -26.4% | 34,588 | +6.3% | 0.00% | 0.0% |
| Q3 2017 | $386,000 | +27.4% | 32,535 | +8.1% | 0.00% | 0.0% |
| Q2 2017 | $303,000 | +14.8% | 30,102 | +32.7% | 0.00% | 0.0% |
| Q1 2017 | $264,000 | +169.4% | 22,681 | +7.1% | 0.00% | – |
| Q4 2016 | $98,000 | -99.9% | 21,181 | -0.3% | 0.00% | -100.0% |
| Q3 2016 | $164,367,000 | +27.9% | 21,236 | +0.2% | 0.00% | 0.0% |
| Q2 2016 | $128,496,000 | -32.4% | 21,204 | -5.0% | 0.00% | 0.0% |
| Q1 2016 | $190,000,000 | -28.6% | 22,316 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $266,000,000 | +118122.2% | 22,316 | -0.2% | 0.00% | 0.0% |
| Q3 2015 | $225,000 | -99.9% | 22,352 | +0.1% | 0.00% | 0.0% |
| Q2 2015 | $370,422,000 | +33.9% | 22,328 | +25.0% | 0.00% | 0.0% |
| Q1 2015 | $276,565,000 | -2.3% | 17,866 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $282,998,000 | +66.2% | 17,866 | +11.9% | 0.00% | 0.0% |
| Q3 2014 | $170,314,000 | +18.1% | 15,962 | +3.9% | 0.00% | 0.0% |
| Q2 2014 | $144,212,000 | +97.8% | 15,358 | +45.3% | 0.00% | – |
| Q1 2014 | $72,912,000 | +81.3% | 10,567 | +2.5% | 0.00% | – |
| Q4 2013 | $40,221,000 | -7.7% | 10,313 | +20.4% | 0.00% | – |
| Q3 2013 | $43,586,000 | – | 8,563 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 5,434,783 | $60,326,000 | 5.25% |
| RA Capital Management | 9,880,323 | $109,672,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,907,492 | $21,173,000 | 1.53% |
| Eversept Partners, LP | 776,323 | $8,617,185 | 1.52% |
| Opaleye Management Inc. | 579,651 | $6,434,000 | 1.26% |
| Sofinnova Investments, Inc. | 811,292 | $9,006,000 | 0.65% |
| Ikarian Capital, LLC | 316,200 | $3,510,000 | 0.57% |
| ARMISTICE CAPITAL, LLC | 800,000 | $8,880,000 | 0.51% |
| 683 Capital Management, LLC | 398,271 | $4,421,000 | 0.51% |
| Frontier Wealth Management LLC | 196,750 | $2,184,000 | 0.35% |